Kestra Medical Technologies, Ltd. (KMTS), a notable player in the healthcare sector, is making waves in the medical instruments and supplies industry. Focused on enhancing cardiovascular patient outcomes through innovative wearable medical devices, Kestra is strategically positioned in the United States market with a robust market cap of $1.57 billion. For investors eyeing the healthcare sector, Kestra’s impressive revenue growth of 53.4% is a key highlight, alongside a potential upside of 7.73% from its current price levels.

**Current Market Performance and Valuation**

Trading at $26.92, Kestra’s stock has shown resilience, fluctuating within a 52-week range of $14.46 to $28.01. The slight recent price dip of 0.54% is minimal…